ATE386122T1 - Neue gbv sequenz - Google Patents

Neue gbv sequenz

Info

Publication number
ATE386122T1
ATE386122T1 AT00935090T AT00935090T ATE386122T1 AT E386122 T1 ATE386122 T1 AT E386122T1 AT 00935090 T AT00935090 T AT 00935090T AT 00935090 T AT00935090 T AT 00935090T AT E386122 T1 ATE386122 T1 AT E386122T1
Authority
AT
Austria
Prior art keywords
gbv
sequence
new
infective
genome
Prior art date
Application number
AT00935090T
Other languages
English (en)
Inventor
Cinzia Traboni
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Application granted granted Critical
Publication of ATE386122T1 publication Critical patent/ATE386122T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00935090T 1999-05-27 2000-05-22 Neue gbv sequenz ATE386122T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9912432.3A GB9912432D0 (en) 1999-05-27 1999-05-27 Novel gbv sequence

Publications (1)

Publication Number Publication Date
ATE386122T1 true ATE386122T1 (de) 2008-03-15

Family

ID=10854332

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00935090T ATE386122T1 (de) 1999-05-27 2000-05-22 Neue gbv sequenz

Country Status (8)

Country Link
US (1) US6627437B1 (de)
EP (1) EP1185663B1 (de)
AT (1) ATE386122T1 (de)
AU (1) AU5069800A (de)
CA (1) CA2375084A1 (de)
DE (1) DE60038023D1 (de)
GB (1) GB9912432D0 (de)
WO (1) WO2000073466A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141405B2 (en) * 1999-06-04 2006-11-28 Board Of Regents, The University Of Texas System Chimeric GB virus B (GBV-B)
US7244585B1 (en) * 1999-06-04 2007-07-17 The Board Of Regents Of The University Of Texas System 3′ Sequence of the GB virus B (GBV-B) genome
US7129342B1 (en) 1999-06-04 2006-10-31 The United States Of America As Represented By The Department Of Health And Human Services Infectious cDNA clone of GB virus B and uses thereof
DK2176408T5 (en) 2008-01-31 2015-12-14 Curevac Gmbh Nucleic acids comprising FORMULA (NuGiXmGnNv) a AND DERIVATIVES AS IMMUNE STIMULATING AGENTS / ADJUVANTS.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995021922A2 (en) * 1994-02-14 1995-08-17 Abbott Laboratories Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
WO2000075337A1 (en) * 1999-06-04 2000-12-14 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services INFECTIOUS cDNA CLONE OF GB VIRUS B AND USES THEREOF

Also Published As

Publication number Publication date
US6627437B1 (en) 2003-09-30
DE60038023D1 (de) 2008-03-27
CA2375084A1 (en) 2000-12-07
GB9912432D0 (en) 1999-07-28
EP1185663A1 (de) 2002-03-13
AU5069800A (en) 2000-12-18
WO2000073466A1 (en) 2000-12-07
EP1185663B1 (de) 2008-02-13

Similar Documents

Publication Publication Date Title
DK1043399T5 (da) Hepatitis C virus cellekultursystem
DE122012000004I1 (de) Peptide als inhibitoren der NS3-Serinprotease des hepatitis c virus.
DE60014345D1 (en) Makrozyklische peptide als hepatitis c virus ns3 protease inhibitore
ID21649A (id) Inhibitor serum protease, terutama virus hepatitis c ns3 protease
HUP0302957A2 (hu) Hepatitis C vírus alkil- és aril-alanin P2 csoportokat tartalmazó makrociklusos NS-3 szerin proteáz inhibitorai
ES2175462T3 (es) Composiciones cristalizables que comprenden un complejo del dominio de proteasa ns3 del virus de la hepatitis c/ns4a, y cristales asi obtenidos.
AU2055301A (en) Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
AU2002230763A8 (en) Inhibitors of hepatitis c virus ns3 protease
DE60138567D1 (de) Diarylrest entfassende peptide als inhibitoren des ns-3 serinproteases von hepatitis c virus
MY140680A (en) Hepatitis c virus inhibitors
IS8448A (is) Lifrarbólgu C-veirutálmar
DE60111509D1 (de) Inhibitoren von serin proteasen, speziell der hepatitis-c-virus ns3-protease
DK1066247T3 (da) Inhibitorer af serinproteaser, især hepatitis C virus NS3 protease
MX9708678A (es) Proteasa activa, soluble del virus de la hepatitis c.
WO2004111082A3 (fr) Composition comprenant la polyproteine ns3/ns4 et le polypeptide ns5b du vhc, vecteurs d'expression incluant les sequences nucleiques correspondantes et leur utilisation en therapeutique
NZ518999A (en) Vaccine compositions
SI0932617T1 (en) Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
MX9708679A (es) Sustratos disociables, solubles de la proteasa del virus de la hepatitis c.
ATE386122T1 (de) Neue gbv sequenz
EP1141255A4 (de) Veränderte formen der hepatitis c virus ns3 protease
De Francesco et al. Mechanisms of hepatitis C virus NS3 proteinase inhibitors
IL137458A0 (en) Genetic immunization with nonstructural proteins of hepatitis c virus
Bianchi et al. Substrate specificity and mechanism of activation of hepatitis C virus protease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties